A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer☆
To access this article, please choose from the options below
☆ Our clinical trial registration numbers are UMIN000001751 and UMIN000001752.
PII: S0169-5002(09)00496-6
doi:10.1016/j.lungcan.2009.09.012
© 2009 Elsevier Ireland Ltd. All rights reserved.
